Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2026-02-02 @ 2:49 AM
Study NCT ID:
NCT05928468
Status:
UNKNOWN
Last Update Posted:
2023-07-03
First Post:
2023-06-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002
Sponsor:
Guangzhou Patronus Biotech Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | COVID-19 | View |
Keywords: